欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Casgevy Human exagamglogene autotemcel Exagamglogene autotemcel EMEA/H/C/005763 Vertex Pharmaceuticals (Ireland) Limited 2024/02/09 Authorised
Mevlyq Human eribulin Eribulin mesylate EMEA/H/C/006134 YES Pharmaceutical Development Services GmbH 2024/02/09 Authorised
Omjjara Human momelotinib Momelotinib dihydrochloride monohydrate EMEA/H/C/005768 GlaxoSmithKline Trading Services Limited 2024/01/25 Authorised
Uzpruvo Human ustekinumab ustekinumab EMEA/H/C/006101 Stada Arzneimittel AG 2024/01/05 Authorised
Rystiggo Human rozanolixizumab rozanolixizumab EMEA/H/C/005824 UCB Pharma 2024/01/05 Authorised
Rimmyrah Human ranibizumab ranibizumab EMEA/H/C/006055 Qilu Pharma Spain S.L. 2024/01/05 Authorised
Azacitidine Kabi Human azacitidine azacitidine EMEA/H/C/006154 Fresenius Kabi Deutschland GmbH 2024/01/05 Authorised
Krazati Human adagrasib adagrasib EMEA/H/C/006013 Bristol-Myers Squibb Pharma EEIG 2024/01/05 Authorised
Spexotras Human trametinib trametinib dimethyl sulfoxide EMEA/H/C/005886 Novartis Europharm Limited 2024/01/05 Authorised
Naveruclif Human paclitaxel paclitaxel EMEA/H/C/006173 Accord Healthcare S.L.U. 2024/01/05 Authorised
Rezzayo Human rezafungin rezafungin EMEA/H/C/005900 Mundipharma GmbH 2023/12/22 Authorised
Loargys Human pegzilarginase Pegzilarginase EMEA/H/C/005484 Immedica Pharma AB 2023/12/15 Authorised
Agamree Human vamorolone vamorolone EMEA/H/C/005679 Santhera Pharmaceuticals (Deutschland) GmbH 2023/12/14 Authorised
Elrexfio Human elranatamab elranatamab EMEA/H/C/005908 Pfizer Europe MA EEIG 2023/12/07 Authorised
Elucirem Human gadopiclenol Gadopiclenol EMEA/H/C/005626 Guerbet 2023/12/07 Authorised
Vueway Human gadopiclenol Gadopiclenol EMEA/H/C/006172 Bracco Imaging S.p.A. 2023/12/07 Authorised
Veoza Human fezolinetant fezolinetant EMEA/H/C/005851 Astellas Pharma Europe B.V. 2023/12/07 Authorised
Zilbrysq Human zilucoplan zilucoplan EMEA/H/C/005450 UCB Pharma S.A.   2023/12/01 Authorised
Pylclari Human piflufolastat (18F) Piflufolastat (18F) EMEA/H/C/005520 Curium Pet France 2023/11/27 Authorised
Yorvipath Human palopegteriparatide palopegteriparatide EMEA/H/C/005934 Ascendis Pharma Bone Diseases A/S 2023/11/17 Authorised

数据库说明:

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase